Table 4. Selection of Proprietary AI Tools and Platforms for AI-Driven Drug Discovery.
| Name of the Platform | Organization | Web link or ref |
|---|---|---|
| Centaur Chemist | Exscientia | Savage et al.106 |
| Pharma.AI (PandaOmics for novel target discovery, Chemistry42 for molecule generation and optimization with ADMET prediction, InClinico for clinical trial prediction) | Insilico Medicine | Kapustina et al.107 |
| Recursion OS | Recursion | Jayatunga et al.108 |
| Chemiverse | Pharos iBio | Gangwal et al.1 |
| Converge | Verge Genomics | https://www.vergegenomics.com/approach |
| Dynamo | Relay Therapeutics | Gangwal et al.1 |
| Benevolent | BenevolentAI | Richardson et al.109 |
| BioNeMo | NVIDIA | https://www.nvidia.com/en-in/clara/bionemo/ |
| Pangea Bio | PangeAI | https://www.pangeabio.com/ |